Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AdaptHealth (AHCO) EPS (Basic) (2018 - 2026)

AdaptHealth has reported EPS (Basic) over the past 8 years, most recently at -$0.74 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 317.65% year-over-year to -$0.74; the TTM value through Dec 2025 reached -$0.52, down 185.25%, while the annual FY2025 figure was -$0.52, 183.87% down from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.74 at AdaptHealth, down from $0.17 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $0.56 in Q2 2021 and troughed at -$3.37 in Q3 2023.
  • A 5-year average of -$0.17 and a median of $0.11 in 2022 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): soared 825.0% in 2022 and later tumbled 9450.0% in 2023.
  • Year by year, EPS (Basic) stood at $0.15 in 2021, then plummeted by 113.33% to -$0.02 in 2022, then tumbled by 9450.0% to -$1.91 in 2023, then surged by 117.8% to $0.34 in 2024, then plummeted by 317.65% to -$0.74 in 2025.
  • Business Quant data shows EPS (Basic) for AHCO at -$0.74 in Q4 2025, $0.17 in Q3 2025, and $0.1 in Q2 2025.